Compound ID | 2475
Class: RNA polymerase inhibitor
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Active against Chlamydia sp., Corynebacterium mediolanum, Mycobacterium bovis, Staphylococcus aureus, and Wolbachia sp. |
Description: | Natural product from Corallococcus (=Myxococcus=Chondrococcus) coralloides strain Cc127 (DSM 2550) |
Institute where first reported: | Univ. of Leeds, UK; Institute for Pharmaceutical Biology, University of Bonn, Germany |
Year first mentioned: | 1985 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Reason Dropped: | Selects for resistance (7.2E-8) and has minimal activity, it was suggested this may be a potential scaffold for investigation and optimisation. |
Chemical structure(s): | |
Canonical SMILES: | C/C=C/C/C=C(\C)/C(CC/C(=C/C=C(\C)/C(=O)C1=C(C=C(C(C)CC/C=C/NC(=O)OC)OC1=O)O)/C)O |
Isomeric SMILES: | C/C=C/C/C=C(\C)/C(CC/C(=C/C=C(\C)/C(=O)C1=C(C=C(OC1=O)C(C)CC/C=C/NC(=O)OC)O)/C)O |
InChI: | InChI=1S/C30H41NO7/c1-7-8-9-12-21(3)24(32)17-15-20(2)14-16-23(5)28(34)27-25(33)19-26(38-29(27)35)22(4)13-10-11-18-31-30(36)37-6/h7-8,11-12,14,16,18-19,22,24,32-33H,9-10,13,15,17H2,1-6H3,(H,31,36)/b8-7+,18-11+,20-14+,21-12+,23-16+ |
InChI Key: | FPBHSTHTCPCNBS-QXMYDWGFSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/135570663 |
External links: | |
Main Source: | https://pubs.rsc.org/en/content/articlepdf/2022/np/d2np00012a |
Citation: | https://www.jstage.jst.go.jp/article/antibiotics1968/38/2/38_2_145/_pdf/-char/en |
Patent: | EP2704708B1 |